ella

ella is a brand name of ulipristal, approved by the FDA in the following formulation(s):

ELLA (ulipristal acetate - tablet; oral)

• 
  Manufacturer: LAB HRA PHARMA
  
  Approval date: August 13, 2010
  
  Strength(s): 30MG ^[RLD]

Has a generic version of ella been approved?

No. There is currently no therapeutically equivalent version of ella available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of ella. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with ella.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 13, 2015 - NEW CHEMICAL ENTITY
  
  

See also...

• Ella Consumer Information (Drugs.com)
• Ella Consumer Information (Wolters Kluwer)
• Ella Consumer Information (Cerner Multum)
• Ella Advanced Consumer Information (Micromedex)
• Ella AHFS DI Monographs (ASHP)
• Ulipristal Consumer Information (Wolters Kluwer)
• Ulipristal Consumer Information (Cerner Multum)
• Ulipristal Advanced Consumer Information (Micromedex)
• Ulipristal acetate Advanced Consumer Information (Micromedex)
• Ulipristal Acetate AHFS DI Monographs (ASHP)